Aza Rakhmanova

Top papers

• Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

  Jan van Lunzen, Franco Maggiolo, José Ramón Arribas, et al.·2011·The Lancet Infectious Diseases
  ↗ 298
• Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

  Amanda Mocroft, Peter Reiss, Jacek Gąsiorowski, et al.·2010·JAIDS Journal of Acquired Immune Deficiency Syndromes
  ↗ 273OA
• The present and future disease burden of hepatitis <scp>C</scp> virus (<scp>HCV</scp>) infections with today's treatment paradigm – volume 2

  Angelos Hatzakis, Vladimir Chulanov, Adrián Gadano, et al.·2015·Journal of Viral Hepatitis
  ↗ 125OA
• Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study

  Catherine Orrell, Debbie Hagins, Elena Belonosova, et al.·2017·The Lancet HIV
  ↗ 117
• Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in select countries – volume 2

  V A Saraswat, Suzanne Norris, Robert J. de Knegt, et al.·2015·Journal of Viral Hepatitis
  ↗ 93OA
• A randomized, double-blind, placebo-controlled trial of TMC125 as 7-day monotherapy in antiretroviral naive, HIV-1 infected subjects

  Б М Груздев, Aza Rakhmanova, Ekaterina Doubovskaya, et al.·2003·AIDS
  ↗ 80
• Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata

  Joanne Reekie, José M. Gatell, Israel Yust, et al.·2011·AIDS
  ↗ 60OA
• Circulation of Subtype A and gagA/envB Recombinant HIV Type 1 Strains among Injecting Drug Users in St. Petersburg, Russia, Correlates with Geographical Origin of Infections

  Vladimir V. Lukashov, Raymond Huismans, Aza Rakhmanova, et al.·1999·AIDS Research and Human Retroviruses
  ↗ 58
• Strategies to manage hepatitis <scp>C</scp> virus (<scp>HCV</scp>) infection disease burden – volume 2

  Edward Gane, David Kershenobich, Carole Seguin‐Devaux, et al.·2015·Journal of Viral Hepatitis
  ↗ 54OA
• Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study

  Joanne Reekie, Justyna Kowalska, Igor Karpov, et al.·2012·PLoS ONE
  ↗ 51OA
• New Insights into the Origin of the HIV Type 1 Subtype A Epidemic in Former Soviet Union's Countries Derived from Sequence Analyses of Preepidemically Transmitted Viruses

  Michael M. Thomson, Elena Vázquez de Parga, Anna Vinogradova, et al.·2007·AIDS Research and Human Retroviruses
  ↗ 44
• Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study

  Anne Marie W. Efsen, Anna Schultze, Robert F. Miller, et al.·2017·Journal of Infection
  ↗ 41OA